An endocannabinoid enhancer (eCBE) is a type of cannabinoidergicdrug that enhances the activity of the endocannabinoid system by increasing extracellular concentrations of endocannabinoids. Examples of different types of eCBEs include fatty acid amide hydrolase (FAAH) inhibitors, monoacylglycerol lipase (MAGL) inhibitors, and endocannabinoid transporter (eCBT) inhibitors (or "endocannabinoid reuptake inhibitors" ("eCBRIs")). An example of an actual eCBE is AM404, the active metabolite of the analgesic paracetamol (acetaminophen; Tylenol) and a dual FAAH inhibitor and eCBRI.
See also
|
|
Phytocannabinoids (comparison) |
| Cannabibutols |
|
| Cannabichromenes |
|
| Cannabicyclols |
|
| Cannabidiols |
|
| Cannabielsoins |
|
| Cannabigerols |
|
| Cannabiphorols |
|
| Cannabinols |
|
| Cannabitriols |
|
| Cannabivarins |
|
| Delta-8-tetrahydrocannabinols |
|
| Delta-9-tetrahydrocannabinols |
|
| Delta-10-Tetrahydrocannabinols |
|
| Miscellaneous cannabinoids |
|
| Active metabolites |
|
|
| Endocannabinoids |
|
Synthetic cannabinoid receptor agonists / neocannabinoids |
Classical cannabinoids (dibenzopyrans) |
|
Non-classical cannabinoids |
|
| Adamantoylindoles |
|
| Benzimidazoles |
|
| Benzoylindoles |
|
| Cyclohexylphenols |
|
| Eicosanoids |
|
| Hydrocarbons |
|
| Indazole carboxamides |
|
Indazole-3- carboxamides |
|
| Indole-3-carboxamides |
|
| Indole-3-carboxylates |
|
| Naphthoylindazoles |
|
| Naphthoylindoles |
|
| Naphthoylpyrroles |
|
| Naphthylmethylindenes |
|
| Naphthylmethylindoles |
|
| Phenylacetylindoles |
|
| Pyrazolecarboxamides |
|
| Pyrrolobenzoxazines |
|
| Quinolinyl esters |
|
Tetramethylcyclo- propanoylindazoles |
|
Tetramethylcyclo- propanoylindoles |
|
Tetramethylcyclo- propylindoles |
|
| Others |
|
|
|
Allosteric CBR ligands
|
|
Endocannabinoid enhancers (inactivation inhibitors)
|
|
Anticannabinoids (antagonists/inverse agonists/antibodies)
|
|
|
|
|
Receptor
|
| CB1 |
|
| CB2 |
-
Agonists: 2-AG
- 2-AGE (noladin ether)
- 3,3'-Diindolylmethane
- 4-O-Methylhonokiol
- α-Amyrin · β-Amyrin
- A-796,260
- A-834,735
- A-836,339
- AM-1172
- AM-1221
- AM-1235
- AM-1241
- AM-2232
- Anandamide
- AZ-11713908
- Cannabinol
- Caryophyllene
- CB-13
- CBS-0550
- CP 55,940
- GW-405,833 (L-768,242)
- GW-842,166X
- HU-308
- JTE 7-31
- JWH-007
- JWH-015
- JWH-018
- JWH-73
- JWH-133
- L-759,633
- L-759,656
- Lenabasum (anabasum)
- Magnolol
- MDA-19
- Nabitan
- NADA
- Olorinab (APD-371)
- PF-03550096
- S-444,823
- SER-601
- Serinolamide A
- UR-144
- Tedalinab
- THC (dronabinol)
- THCV
- Tetrahydromagnolol
- Virodhamine
|
NAGly (GPR18) |
|
| GPR55 |
|
| GPR119 |
|
| Unsorted |
|
|
Transporter
|
|
Enzyme
|
|
| Others |
-
Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)
-
ARN-272 (FAAH-like anandamide transporter inhibitor)
|
|